Sensorion encouraged by deafness gene therapy data

Sensorion encouraged by deafness gene therapy data

Source: 
Pharmaphorum
snippet: 

Sensorion's gene therapy for otoferlin-related hearing loss – a congenital form of deafness – has shown early signs of improving hearing in two toddlers treated in a phase 1/2 trial.